Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 44Liver Neoplasms 18Colorectal Neoplasms 15Neoplasm Metastasis 11Cholangiocarcinoma 11Pancreatic Neoplasms 9Colonic Neoplasms 9Barrett Esophagus 7Rectal Neoplasms 6Recurrence 5Esophageal Neoplasms 4Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Hepatitis B 2Gallbladder Neoplasms 2Stomach Neoplasms 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Pancreatic cancer, adult 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Micrometastasis 1Multi-organ Metastatic Colorectal Cancer 1Liver Metastasis Colon Cancer 1Klatskin Tumor 1Jaundice, Obstructive 1Hypertension, Portal 1Hepatitis B, Chronic 1

Interventions

Radiofrequency Ablation 1Gemcitabine 1Albumin-Bound Paclitaxel 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholestasis × Radiofrequency Ablation × Gastrointestinal × Clear all
NCT02582541 2015-10-21

Endoscopic Biliary RFA of Malignant Bile Duct Obstruction

The Second Hospital of Nanjing Medical University

Phase NA Unknown
100 enrolled
Gastrointestinal

Cholestasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡